Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease

http://thorax.bmj.com/content/68/7/670.full?utm_source=landingpage&utm_medium=Link4&utm_campaign=ATS&utm_source=marketing_email&utm_medium=email&utm_campaign=Thorax_ATS&utm_content=HT_A4&utm_term=


Conclusions Fibrinogen is likely to be a useful biomarker to stratify individuals with COPD into those with a high or low risk of future exacerbations and may identify those with a higher risk of mortality.